Making real progress against breast cancer
Some of the best cancer news in 2005 has been the success of targeted approaches to treating breast cancer.
Talk to any breast cancer specialist who attended the May 2005 American Society of Clinical Oncology (ASCO) meeting — the largest annual gathering of cancer researchers and clinicians in the world — and you're likely to detect excitement in their voices. This was a year when they heard results that could markedly change the way they take care of their patients. The buzz was about targeted therapy, that is, treatment aimed directly at gene products (proteins) and other factors responsible for cancerous cell growth.